32 results on '"Yamada, Ryo"'
Search Results
2. Gene-based large scale LD-mapping of rheumatoid arthritis-associated genes
- Author
-
Yamada, Ryo, Yamamoto, Kazuhiko, Parnham, Michael J., editor, and Holmdahl, Rikard, editor
- Published
- 2006
- Full Text
- View/download PDF
3. A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations
- Author
-
Meziani, Roubila, Yamada, Ryo, Takahashi, Meiko, Ohigashi, Kenei, Morinobu, Akio, Terao, Chikashi, Hiratani, Hitomi, Ohmura, Koichiro, Yamaguchi, Masao, Nomura, Takashi, Vasilescu, Alexandre, Kokubo, Miki, Renault, Victor, Hirosawa, Katsura, Ratanajaraya, Chanavee, Heath, Simon, Mimori, Tsuneyo, Sakaguchi, Shimon, Lathrop, Mark, Melchers, Inga, Kumagai, Shunichi, and Matsuda, Fumihiko
- Published
- 2012
- Full Text
- View/download PDF
4. SLC22A4 and RUNX1: identification of RA susceptible genes
- Author
-
Yamada, Ryo, Tokuhiro, Shinya, Chang, Xiotian, and Yamamoto, Kazuhiko
- Published
- 2004
- Full Text
- View/download PDF
5. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
- Author
-
Akari Suzuki, Yuta Kochi, Hirofumi Shoda, Yu Seri, Keishi Fujio, Tetsuji Sawada, Ryo Yamada, Kazuhiko Yamamoto, Suzuki, Akari, Kochi, Yuta, Shoda, Hirofumi, Seri, Yu, Fujio, Keishi, Sawada, Tetsuji, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
GENETICS of rheumatoid arthritis ,GENOMICS ,GENE expression ,IMMUNOHISTOCHEMISTRY ,SEVERITY of illness index ,AMINO acid metabolism ,AMINO acids ,ANIMAL experimentation ,ARTHRITIS ,AUTOANTIBODIES ,AUTOIMMUNE diseases ,COLLAGEN ,CYTOKINES ,DISEASE susceptibility ,ENZYME-linked immunosorbent assay ,HYDROLASES ,MICE ,RHEUMATOID arthritis ,TUMOR necrosis factors ,DISEASE progression ,SEQUENCE analysis - Abstract
Background: Peptidylarginine deiminase type 4 (PADI4) has been identified as a susceptibility gene for rheumatoid arthritis (RA) by genome-wide association studies. PADI4 is highly expressed in the bone marrow, macrophages, neutrophils, and monocytes. Peptidyl citrulline is an interesting molecule in RA because it is a target antigen for anti-citrullinated peptide antibodies, and only PADs (translated proteins from PADI genes) can provide peptidyl citrulline via the modification of protein substrates. The aim of this study was to evaluate the importance of the PADI4 gene in the progression of RA.Methods: We generated Padi4 knockout (Padi4(-/-)) DBA1J mice. The Padi4(-/-) DBA1J and wild-type mice were immunized with bovine type II collagen (CII) to develop collagen-induced arthritis (CIA). The expression of various inflammatory cytokines and Padi genes in immune cells was detected by the real-time TaqMan assay. Cytokine concentrations in sera were measured by enzyme-linked immunosorbent assays. Localization of the PAD4 and PAD2 proteins was indicated by immunohistochemistry.Results: We demonstrated that the clinical disease score was significantly decreased in the Padi4(-/-) mice and Padi4 expression was induced by CII immunization. In the Padi4(-/-) mice, serum anti-type II collagen (CII) immunoglobulin M (IgM), IgG, and inflammatory cytokine levels were significantly decreased compared with those in the wild-type mice. Padi2 expression was induced in the immune cells of the Padi4(-/-) mice as a compensation for the defect in Padi4.Conclusions: Padi4 affected disease severity in the CIA mice and was involved in the enhancement of the collagen-initiated inflammatory responses. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
6. Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis.
- Author
-
Kimura, Eri, Kanzaki, Takeyuki, Tahara, Koichiro, Hayashi, Haeru, Hashimoto, Shiori, Suzuki, Akari, Yamada, Ryo, Yamamoto, Kazuhiko, and Sawada, Tetsuji
- Subjects
RHEUMATOID arthritis diagnosis ,FIBRONECTINS ,SYNOVIAL fluid ,CITRULLINE ,OSTEOARTHRITIS ,IMMUNOPRECIPITATION ,ENZYME-linked immunosorbent assay - Abstract
Objectives. Cellular fibronectin (cFn) has been implicated in the pathogenesis of rheumatoid arthritis (RA), and we previously demonstrated the presence of citrullinated cFn in rheumatoid synovial tissues. The present study aimed to investigate whether citrullinated cFn can be detected in the plasma or synovial fluid of RA patients. Methods. Twenty-five rheumatoid arthritis synovial fluid (RASF), seven osteoarthritis synovial fluid (OASF) and 12 plasma samples from RA patients were examined. Citrullination of cFn was determined by immunoprecipitation (IP), western blotting and enzyme-linked immunosorbent assay (ELISA), in which peptidyl-citrulline within cFn was detected using a specific anti-cFn monoclonal antibody in combination with anti-modified citrulline antibody after chemical modification. Results. Levels of citrullination associated with cFn, as determined by ELISA, were significantly higher in RASF than in OASF samples. IP and western blotting detected citrullinated cFn in RASF but not in plasma samples from RA patients. Levels of total cFn were elevated in RASF compared with OASF, and 24 out of 25 RASF samples were positive for anti-CCP antibody. However, no correlation was observed between levels of citrullinated cFn and those of total cFn or anti-CCP antibody in RASF. On the other hand, a significant positive correlation was observed between the levels of matrix metalloproteinase-3 (MMP-3) and cFn citrullination in RASF. Conclusions. Citrullinated cFn appears to be produced within the affected joint and might be involved in the pathogenesis of rheumatoid synovitis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes.
- Author
-
Shimane, Kenichi, Kochi, Yuta, Suzuki, Akari, Okada, Yukinori, Ishii, Tomonori, Horita, Tetsuya, Saito, Kazuyoshi, Okamoto, Akiko, Nishimoto, Norihiro, Myouzen, Keiko, Kubo, Michiaki, Hirakata, Michito, Sumida, Takayuki, Takasaki, Yoshinari, Yamada, Ryo, Nakamura, Yusuke, Kamatani, Naoyuki, and Yamamoto, Kazuhiko
- Subjects
GENETICS of rheumatoid arthritis ,SYSTEMIC lupus erythematosus ,ACADEMIC medical centers ,AUTOANTIBODIES ,CHI-squared test ,CONFIDENCE intervals ,EPIDEMIOLOGY ,FISHER exact test ,GENES ,STATISTICS ,U-statistics ,LOGISTIC regression analysis ,GENOMICS ,DATA analysis ,DATA analysis software ,GENETICS - Abstract
Objective. To re-evaluate the roles of HLA-DRB1 alleles in susceptibility to SLE and RA and their effects on autoantibody status in large-scale Japanese cohorts.Methods. A total of 656 SLE, 2410 RA and 911 control subjects, who were all Japanese, were genotyped for HLA-DRB1 alleles using sequence-specific oligonucleotide probes. The association of alleles with disease susceptibility was tested by logistic regression analysis and by the relative predispositional effect method. The association with autoantibody status was examined by the standard χ2 test.Results. HLA-DRB1*15:01, *09:01, *08:02 and *04:01 were significantly associated with SLE susceptibility, while shared epitope (SE) alleles and DRB1*09:01 were associated with RA susceptibility. The compound heterozygote of DRB1*09:01/*15:01 conferred an increased risk for SLE compared with the homozygotes for DRB1*09:01 and *15:01 and was associated with earlier onset of disease, whereas the compound effect of DRB1-SE/*09:01 was not clear in RA. DRB1*09:01 was significantly associated with the appearance of anti-Sm antibody in SLE as well as ACPA in RA, while protectively associated with anti-dsDNA antibody in SLE. No significant interaction was observed between DRB1*09:01 and smoking status for the appearance of ACPA, unlike that observed in SE alleles in RA.Conclusion. We identified HLA-DRB1 alleles associated with SLE and RA in a Japanese population and demonstrated a shared susceptibility of DRB1*09:01 between the diseases as well as its effect on autoantibody production. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
8. Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis – Analysis Using More than 17,000 Assessments in the KURAMA Database.
- Author
-
Terao, Chikashi, Hashimoto, Motomu, Yamamoto, Keiichi, Murakami, Kosaku, Ohmura, Koichiro, Nakashima, Ran, Yamakawa, Noriyuki, Yoshifuji, Hajime, Yukawa, Naoichiro, Kawabata, Daisuke, Usui, Takashi, Yoshitomi, Hiroyuki, Furu, Moritoshi, Yamada, Ryo, Matsuda, Fumihiko, Ito, Hiromu, Fujii, Takao, and Mimori, Tsuneyo
- Subjects
RHEUMATOID arthritis ,SYNOVITIS ,AUTOIMMUNE diseases ,SYMPTOMS ,PATHOLOGICAL physiology ,CLINICAL epidemiology ,RHEUMATOLOGY ,PUBLIC health - Abstract
Rheumatoid arthritis (RA) is a joint-destructive autoimmune disease. Three composite indices evaluating the same 28 joints are commonly used for the evaluation of RA activity. However, the relationship between, and the frequency of, the joint involvements are still not fully understood. Here, we obtained and analyzed 17,311 assessments for 28 joints in 1,314 patients with RA from 2005 to 2011 from electronic clinical chart templates stored in the KURAMA (Kyoto University Rheumatoid Arthritis Management Alliance) database. Affected rates for swelling and tenderness were assessed for each of the 28 joints and compared between two different sets of RA patients. Correlations of joint symptoms were analyzed for swellings and tenderness using kappa coefficient and eigen vectors by principal component analysis. As a result, we found that joint affected rates greatly varied from joint to joint both for tenderness and swelling for the two sets. Right wrist joint is the most affected joint of the 28 joints. Tenderness and swellings are well correlated in the same joints except for the shoulder joints. Patients with RA tended to demonstrate right-dominant joint involvement and joint destruction. We also found that RA synovitis could be classified into three categories of joints in the correlation analyses: large joints with wrist joints, PIP joints, and MCP joints. Clustering analysis based on distribution of synovitis revealed that patients with RA could be classified into six subgroups. We confirmed the symmetric joint involvement in RA. Our results suggested that RA synovitis can be classified into subgroups and that several different mechanisms may underlie the pathophysiology in RA synovitis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
9. Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in Japanese. .
- Author
-
Myouzen, Keiko, Kochi, Yuta, Okada, Yukinori, Terao, Chikashi, Suzuki, Akari, Ikari, Katsunori, Tsunoda, Tatsuhiko, Takahashi, Atsushi, Kubo, Michiaki, Taniguchi, Atsuo, Matsuda, Fumihiko, Ohmura, Koichiro, Momohara, Shigeki, Mimori, Tsuneyo, Yamanaka, Hisashi, Kamatani, Naoyuki, Yamada, Ryo, Nakamura, Yusuke, and Yamamoto, Kazuhiko
- Subjects
RHEUMATOID arthritis ,GENOMES ,GENES ,JAPANESE people ,ALLELES - Abstract
Rheumatoid arthritis is an autoimmune disease with a complex etiology, leading to inflammation of synovial tissue and joint destruction. Through a genome-wide association study (GWAS) and two replication studies in the Japanese population (7,907 cases and 35,362 controls), we identified two gene loci associated with rheumatoid arthritis susceptibility (NFKBIE at 6p21.1, rs2233434, odds ratio (OR) = 1.20, P = 1.3 x 10
-15 ; RTKN2 at 10q21.2, rs3125734, OR = 1.20, P = 4.6 x 10-9 ). In addition to two functional non-synonymous SNPs in NFKBIE, we identified candidate causal SNPs with regulatory potential in NFKBIE and RTKN2 gene regions by integrating in silico analysis using public genome databases and subsequent in vitro analysis. Both of these genes are known to regulate the NF-κB pathway, and the risk alleles of the genes were implicated in the enhancement of NF-κB activity in our analyses. These results suggest that the NF-κB pathway plays a role in pathogenesis and would be a rational target for treatment of rheumatoid arthritis. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
10. ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese.
- Author
-
Terao, Chikashi, Ohmura, Koichiro, Ikari, Katsunori, Kochi, Yuta, Maruya, Etsuko, Katayama, Masaki, Yurugi, Kimiko, Shimada, Kota, Murasawa, Akira, Honjo, Shigeru, Takasugi, Kiyoshi, Matsuo, Keitaro, Tajima, Kazuo, Suzuki, Akari, Yamamoto, Kazuhiko, Momohara, Shigeki, Yamanaka, Hisashi, Yamada, Ryo, Saji, Hiroo, and Matsuda, Fumihiko
- Subjects
RHEUMATOID arthritis ,JAPANESE people ,ALLELES ,ZYGOTES ,AUTOIMMUNE diseases ,BLOOD hyperviscosity syndrome ,HEALTH - Abstract
HLA-DRB1, especially the shared epitope (SE), is strongly associated with rheumatoid arthritis (RA). However, recent studies have shown that SE is at most weakly associated with RA without anti-citrullinated peptide/protein antibody (ACPA). We have recently reported that ACPA-negative RA is associated with specific HLA-DRB1 alleles and diplotypes. Here, we attempted to detect genetically different subsets of ACPA-negative RA by classifying ACPA-negative RA patients into two groups based on their positivity for rheumatoid factor (RF). HLA-DRB1 genotyping data for totally 954 ACPA-negative RA patients and 2,008 healthy individuals in two independent sets were used. HLA-DRB1 allele and diplotype frequencies were compared among the ACPA-negative RF-positive RA patients, ACPA-negative RF-negative RA patients, and controls in each set. Combined results were also analyzed. A similar analysis was performed in 685 ACPA-positive RA patients classified according to their RF positivity. As a result, HLA-DRB1*04:05 and *09:01 showed strong associations with ACPA-negative RFpositive RA in the combined analysis (p = 8.8×10
-6 and 0.0011, OR: 1.57 (1.28-1.91) and 1.37 (1.13-1.65), respectively). We also found that HLA-DR14 and the HLA-DR8 homozygote were associated with ACPA-negative RF-negative RA (p = 0.00022 and 0.00013, OR: 1.52 (1.21-1.89) and 3.08 (1.68-5.64), respectively). These association tendencies were found in each set. On the contrary, we could not detect any significant differences between ACPA-positive RA subsets. As a conclusion, ACPAnegative RA includes two genetically distinct subsets according to RF positivity in Japan, which display different associations with HLA-DRB1. ACPA-negative RF-positive RA is strongly associated with HLA-DRB1*04:05 and *09:01. ACPA-negative RF-negative RA is associated with DR14 and the HLA-DR8 homozygote. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
11. Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis--A Genome-Wide Study Combined with Immunological Analyses.
- Author
-
Terao, Chikashi, Ohmura, Koichiro, Katayama, Masaki, Takahashi, Meiko, Kokubo, Miki, Diop, Gora, Toda, Yoshinobu, Yamamoto, Natsuki, Shinkura, Reiko, Shimizu, Masakazu, Gut, Ivo, Heath, Simon, Melchers, Inga, Manabe, Toshiaki, Lathrop, Mark, Mimori, T. suneyo, Yamada, Ryo, and Matsuda, Fumihiko
- Subjects
MYELIN basic protein ,RHEUMATOID arthritis ,GENOMES ,IMMUNOLOGY ,INFLAMMATION ,DISEASE susceptibility ,IMMUNOGLOBULINS ,CHROMOSOMES ,CONNECTIVE tissues - Abstract
Rheumatoid arthritis (RA) is a major cause of adult chronic inflammatory arthritis and a typical complex trait. Although several genetic determinants have been identified, they account for only a part of the genetic susceptibility. We conducted a genome-wide association study of RA in Japanese using 225,079 SNPs genotyped in 990 cases and 1,236 controls from two independent collections (658 cases and 934 controls in collection1; 332 cases and 302 controls in collection2), followed by replication studies in two additional collections (874 cases and 855 controls in collection3; 1,264 cases and 948 controls in collection4). SNPs showing p,0.005 in the first two collections and p,10
-4 by meta-analysis were further genotyped in the latter two collections. A novel risk variant, rs2000811, in intron2 of the myelin basic protein (MBP) at chromosome 18q23 showed strong association with RA (p = 2.7×10-8 , OR 1.23, 95% CI: 1.14-1.32). The transcription of MBP was significantly elevated with the risk allele compared to the alternative allele (p,0.001). We also established by immunohistochemistry that MBP was expressed in the synovial lining layer of RA patients, the main target of inflammation in the disease. Circulating autoantibody against MBP derived from human brain was quantified by ELISA between patients with RA, other connective tissue diseases and healthy controls. As a result, the titer of anti-MBP antibody was markedly higher in plasma of RA patients compared to healthy controls (p,0.001) and patients with other connective tissue disorders (p,0.001). ELISA experiment using citrullinated recombinant MBP revealed that a large fraction of anti-MBP antibody in RA patients recognized citrullinated MBP. This is the first report of a genetic study in RA implicating MBP as a potential autoantigen and its involvement in pathogenesis of the disease. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
12. Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis.
- Author
-
Ohmura, Koichiro, Terao, Chikashi, Maruya, Etsuko, Katayama, Masaki, Matoba, Kenichiro, Shimada, Kota, Murasawa, Akira, Honjo, Shigeru, Takasugi, Kiyoshi, Tohma, Shigeto, Matsuo, Keitaro, Tajima, Kazuo, Yukawa, Naoichiro, Kawabata, Daisuke, Nojima, Takaki, Fujii, Takao, Yamada, Ryo, Saji, Hiroo, Matsuda, Fumihiko, and Mimori, Tsuneyo
- Subjects
RHEUMATOID arthritis ,BIOMARKERS ,AUTOANTIBODIES ,RHEUMATOLOGY ,BONE diseases ,EPITOPES ,GENETICS - Abstract
Objectives. ACPA is a highly specific marker for RA. It was recently reported that ACPA can be used to classify RA into two disease subsets, ACPA-positive and ACPA-negative RA. ACPA-positive RA was found to be associated with the HLA-DR shared epitope (SE), but ACPA negative was not. However, the suspicion remained that this result was caused by the ACPA-negative RA subset containing patients with non-RA diseases. We examined whether this is the case even when possible non-RA ACPA-negative RA patients were excluded by selecting only patients with bone erosion.Methods. We genotyped HLA-DRB1 alleles for 574 ACPA-positive RA, 185 ACPA-negative RA (including 97 erosive RA) and 1508 healthy donors. We also tested whether HLA-DR SE is associated with RF-negative or ANA-negative RA.Results. ACPA-negative RA with apparent bone erosion was not associated with SE, supporting the idea that ACPA-negative RA is genetically distinct from ACPA-positive RA. We also tested whether these subsets are based on autoantibody-producing activity. In accordance with the ACPA-negative RA subset, the RF-negative RA subset showed a clearly distinct pattern of association with SE from the RF-positive RA. In contrast, ANA-negative as well as ANA-positive RA was similarly associated with SE, suggesting that the subsets distinguished by ACPA are not based simply on differences in autoantibody production.Conclusions. ACPA-negative erosive RA is genetically distinct from ACPA-positive RA. [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
13. POSH promotes cell survival in Drosophila and in human RASF cells
- Author
-
Tsuda, Manabu, Kawaida, Reimi, Kobayashi, Kyoko, Shinagawa, Akira, Sawada, Tetsuji, Yamada, Ryo, Yamamoto, Kazuhiko, and Aigaki, Toshiro
- Subjects
SCAFFOLD proteins ,JNK mitogen-activated protein kinases ,DROSOPHILA ,RHEUMATOID arthritis ,FIBROBLASTS ,CELL death ,LIGANDS (Biochemistry) ,TUMOR necrosis factors - Abstract
Abstract: In Drosophila, Eiger, a tumor necrosis factor α (TNFα) superfamily ligand, induces cell death by activating the c-Jun N-terminal kinase (JNK) pathway. Here, we report that overexpression of Plenty of SH3s (POSH) suppresses Eiger-induced cell death and produces highly deformed tissues. These results imply that high levels of POSH protect tissues from cell death. In humans, rheumatoid arthritis synovial fibroblasts (RASF) are generally resistant to apoptosis. We show that POSH is expressed at relatively high levels in RASF, and its reduction by RNAi sensitizes these cells to Fas-mediated apoptosis. Thus, we demonstrate that POSH promotes cell survival in Drosophila and in human RASF. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
14. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.
- Author
-
Kochi, Yuta, Okada, Yukinori, Suzuki, Akari, Ikari, Katsunori, Terao, Chikashi, Takahashi, Atsushi, Yamazaki, Keiko, Hosono, Naoya, Myouzen, Keiko, Tsunoda, Tatsuhiko, Kamatani, Naoyuki, Furuichi, Tatsuya, Ikegawa, Shiro, Ohmura, Koichiro, Mimori, Tsuneyo, Matsuda, Fumihiko, Iwamoto, Takuji, Momohara, Shigeki, Yamanaka, Hisashi, and Yamada, Ryo
- Subjects
RHEUMATOID arthritis ,AUTOIMMUNE diseases ,GENETIC polymorphisms ,CROHN'S disease ,GENETIC research - Abstract
Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here, through a genome-wide association study of rheumatoid arthritis, we identified a polymorphism in CCR6, the gene encoding chemokine (C-C motif) receptor 6 (a surface marker for Th17 cells) at 6q27, that was associated with rheumatoid arthritis susceptibility and was validated in two independent replication cohorts from Japan (rs3093024, a total of 7,069 individuals with rheumatoid arthritis (cases) and 20,727 controls, overall odds ratio = 1.19, P = 7.7 × 10
−19 ). We identified a triallelic dinucleotide polymorphism of CCR6 (CCR6DNP) in strong linkage disequilibrium with rs3093024 that showed effects on gene transcription. The CCR6DNP genotype was correlated with the expression level of CCR6 and was associated with the presence of interleukin-17 (IL-17) in the sera of subjects with rheumatoid arthritis. Moreover, CCR6DNP was associated with susceptibility to Graves' and Crohn's diseases. These results suggest that CCR6 is critically involved in IL-17–driven autoimmunity in human diseases. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
15. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population.
- Author
-
Suzuki, Akari, Yamada, Ryo, Kochi, Yuta, Sawada, Tetsuji, Okada, Yukinori, Matsuda, Koichi, Kamatani, Yoichiro, Mori, Mikako, Shimane, Kenichi, Hirabayashi, Yasuhiko, Takahashi, Atsushi, Tsunoda, Tatsuhiko, Miyatake, Akihiko, Kubo, Michiaki, Kamatani, Naoyuki, Nakamura, Yusuke, and Yamamoto, Kazuhiko
- Subjects
- *
CD antigens , *MEDICAL genetics , *ETIOLOGY of diseases , *RHEUMATOID arthritis , *JOINT diseases , *AUTOIMMUNE diseases , *JAPANESE people - Abstract
Rheumatoid arthritis is a chronic autoimmune inflammatory disease with a complex genetic etiology. Members of the signaling lymphocyte activation molecule (SLAM) family carry out pivotal functions in innate immunity and in conventional lymphocytes. We identified a linkage disequilibrium block associated with rheumatoid arthritis in the chromosome 1q region containing multiple SLAM family genes. In this block, the association peaked at two functional SNPs (rs3766379 and rs6682654) in CD244 in two independent rheumatoid arthritis cohorts from Japan (P = 3.23 × 10−8 and P = 7.45 × 10−8). We also identified a Japanese cohort with systemic lupus erythematosus that had a similar genotype distribution as the rheumatoid arthritis cohorts. We demonstrated that the rheumatoid arthritis–susceptible alleles of rs3766379 and rs6682654 and their haplotype increased their expression in luciferase and allele-specific transcript quantification assays. CD244 is a genetic risk factor for rheumatoid arthritis and may have a role in the autoimmune process shared by rheumatoid arthritis and systemic lupus erythematosus. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
16. Citrullinated Fibrinogen Inhibits Thrombin-catalysed Fibrin Polymerization.
- Author
-
Nakayama-Hamada, Makiko, Suzuki, Akari, Furukawa, Hidehiko, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
ARGININE ,FIBRINOGEN ,BLOOD coagulation factors ,RHEUMATOID arthritis ,ORNITHINE carbamoyltransferase - Abstract
Citrullination is the post-translational modification of arginine residues by peptidylarginine deiminases (PADIs). Fibrinogen is one substrate of PADIs under physiological conditions. Fibrinogen is an important factor for blood coagulation and inducing inflammation. The citrullinated form of fibrinogen appears in rheumatoid arthritis synovial tissue together with the production of autoantibodies that target self-peptides containing citrulline. However, whether the function of fibrinogen changes after citrullination remains unclear. We found that citrullinated fibrinogen markedly impairs the function of thrombin-catalysed fibrin polymerization and also inhibits fibrin formation. Increased citrullinated fibrinogen might thus affect the balance between coagulation and fibrinolysis and alter antigenicity under physiological conditions. These data suggest that citrullination of proteins could physiologically change functions and subsequently generate pro-inflammatory conditions and autoimmune reactions. [ABSTRACT FROM PUBLISHER]
- Published
- 2008
- Full Text
- View/download PDF
17. Mechanisms of Disease: genetics of rheumatoid arthritis—ethnic differences in disease-associated genes.
- Author
-
Yamada, Ryo and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *ARTHRITIS , *AUTOIMMUNE diseases , *JOINT diseases , *MEDICAL genetics , *HUMAN genetics , *GENETIC disorders - Abstract
Large studies on the genetics of common rheumatic diseases, such as rheumatoid arthritis and systemic lupus erythematosus, have identified multiple polymorphisms related to disease susceptibility, including peptidylarginine deiminase 4 (PADI4) and protein tyrosine phosphatase N22 (PTPN22). Some of the identified genes are associated with multiple autoimmune disorders, and some seem to have unique associations with particular disease entities. Although the molecules encoded by these genes have a primary role in the molecular pathways of autoimmunity, genetic variations and contribution to disease susceptibility seem to vary between ethnic groups. In this Review, we report the findings on genes associated with rheumatoid arthritis and focus on the differences in the frequency of polymorphisms between various ethnic groups. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
18. Citrullination by Peptidylarginine Deiminase in Rheumatoid Arthritis.
- Author
-
SUZUKI, AKARI, YAMADA, RYO, and YAMAMOTO, KAZUHIKO
- Subjects
- *
RHEUMATOID arthritis , *AUTOIMMUNE diseases , *IMMUNOGLOBULINS , *EXTRACELLULAR matrix proteins , *NUCLEOTIDES , *IMMUNE system , *AUTOIMMUNITY , *AUTOANTIBODIES , *MEDICAL research - Abstract
Rheumatoid arthritis (RA) is a complex, multifactorial disease with genetic and immunological aspects. Because RA is an autoimmune condition, dysregulation of the immune system is implied. Many linkage and association studies have also indicated that multiple genetic factors are associated with RA. Although the contribution of each genetic factor is small, the combination of these factors affects RA development. Previous studies have suggested that genetic changes affect the internal immunological environment, which results in autoimmune diseases. More recent genetic studies indicate that the HLA-DRB gene is the predominant cause of RA and that other non-HLA genes are also involved. We reported that peptidylarginine deiminase (gene name abbreviated to PADI, protein name abbreviated to PAD) type 4 is the one of the non-HLA genetic factors involved in RA via citrullination. Antibodies against citrullinated proteins/peptides are highly specific to RA, but the physiological roles of PADI gene, PAD proteins as their products and citrullinated proteins/peptides are obscure. However, levels of anticitrullinated protein antibodies are apparently also increased and were involved in the pathogenesis of autoimmune arthritis in mice with collagen-induced arthritis (CIA). These data suggested that citrullinated protein and anticitrullinated protein antibodies play important roles in the development of RA. This review summarizes the relationship between RA and citrullination, as well as the role of PADI4 genetics. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
19. Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis
- Author
-
Yamamoto, Kazuhiko and Yamada, Ryo
- Subjects
- *
NUCLEOTIDES , *GENETIC polymorphisms , *RHEUMATOID arthritis , *AUTOIMMUNE diseases - Abstract
Abstract: Because of the limitations of candidate gene studies and linkage analyses for common diseases, genome-wide association studies are now recognized as a powerful approach to mapping responsible genes with modest effects on various diseases. We performed whole genome case-control linkage disequilibrium (LD) mapping for rheumatoid arthritis (RA)-associated genes in Japanese subjects using single nucleotide polymorphisms (SNPs) mainly discovered in gene-containing regions. We identified RA-associated polymorphisms in two genes/loci, PADI4 and SLC22A4/A5 cluster. PADI4 catalyzes the conversion of arginine residues to citrulline in proteins. Recent reports on the high specificity of autoantibodies against citrullinated proteins to RA and the results of our study suggest that citrullination by PADI4 is a fundamental phenomenon of RA. On the other hand, the functions of SLC22A4/A5 have not been studied in detail, but SLC22A4/A5 have been reported to have multiple polymorphisms associated with several autoimmune diseases. Thus, large-scale LD mapping appears to be effective for identifying RA-associated polymorphisms. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
20. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis
- Author
-
Suzuki, Akari, Yamada, Ryo, Ohtake-Yamanaka, Miyako, Okazaki, Yuko, Sawada, Tetsuji, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *COLLAGEN , *IMMUNOGLOBULINS , *ARTHRITIS - Abstract
Abstract: Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, but its autoimmune mechanisms are not clearly understood. Recently, anti-citrullinated peptide antibodies have been specifically observed in sera of RA patients. Furthermore, we identified RA-susceptible variant in a gene encoding citrullinating enzyme, peptidylarginine deiminase type 4 (PADI4). Therefore, we hypothesized that proteins which are modified in RA synovium by PADI4 act as autoantigens. Subsequently, we obtained human collagen type I (huCI) as one of the autoantigens using a RA synoviocyte cDNA library by immunoscreening. We also investigated that the levels of anti-citrullinated huCI were significantly higher in RA patient sera than in normal control sera with high specificity (99%) and positively correlated with the levels of anti-cyclic citrullinated peptide (anti-CCP) antibodies. We concluded that huCI is a novel substrate protein of PADIs and that citrullinated huCI is a candidate autoantigen of RA. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
21. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
- Author
-
Kochi, Yuta, Yamada, Ryo, Suzuki, Akari, Harley, John B, Shirasawa, Senji, Sawada, Tetsuji, Bae, Sang-Cheol, Tokuhiro, Shinya, Chang, Xiaotian, Sekine, Akihiro, Takahashi, Atsushi, Tsunoda, Tatsuhiko, Ohnishi, Yozo, Kaufman, Kenneth M, Kang, Changsoo Paul, Kang, Changwon, Otsubo, Shigeru, Yumura, Wako, Mimori, Akio, and Koike, Takao
- Subjects
- *
RHEUMATOID arthritis , *AUTOANTIBODIES , *ETIOLOGY of diseases , *GENETIC polymorphisms , *B cells , *GENOMES - Abstract
Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here we identify a SNP in the promoter region of FCRL3, a member of the Fc receptor-like family, that is associated with susceptibility to rheumatoid arthritis (odds ratio = 2.15, P = 0.00000085). This polymorphism alters the binding affinity of nuclear factor-?B and regulates FCRL3 expression. We observed high FCRL3 expression on B cells and augmented autoantibody production in individuals with the disease-susceptible genotype. We also found associations between the SNP and susceptibility to autoimmune thyroid disease and systemic lupus erythematosus. FCRL3 may therefore have a pivotal role in autoimmunity. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
22. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis
- Author
-
Yamada, Ryo
- Subjects
- *
RHEUMATOID arthritis , *SERODIAGNOSIS , *IMMUNOGLOBULINS , *PEPTIDES , *AUTOIMMUNITY - Abstract
Abstract: Anticitrullinated peptide antibodies seem to be one of the most clinically reliable serologic markers for rheumatoid arthritis (RA). A genetic approach revealed that one of the citrullinating enzymes has a RA-susceptible variant. Peptidyl citrullination alters the chemical character of peptides and, subsequently, their antigenicity as well. This change in antigenicity of self-peptides seems to invoke citrulline-related autoimmunity. Although the precise physiologic role of citrullination is still unknown, accumulating data indicate that citrullination has a definite role in biologic phenomena, along with other posttranslational protein modifications, such as methylation and phosphorylation. In RA synovial tissue, two of five PADI isotypes are known to be expressed, and their expression is regulated at multiple steps: transcription, translation, intracellular localization, and activation/inactivation of PADI proteins. Further investigations on citrulline and PADIs from various aspects will provide a more profound understanding of RA-related autoimmunity. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
23. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.
- Author
-
Tokuhiro, Shinya, Yamada, Ryo, Suzuki, Akari, Kochi, Yuta, Sawada, Tetsuji, Suzuki, Masakatsu, Nagasaki, Miyuki, Ohtsuki, Masahiko, Ono, Mitsuru, Chang, Xiaotian, Furukawa, Hidehiko, Nagashima, Masakazu, Yoshino, Shinichi, Mabuchi, Akihiko, Sekine, Akihiro, Saito, Susumu, Takahashi, Atsushi, Tsunoda, Tatsuhiko, Nakamura, Yusuke, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *TRANSCRIPTION factors , *BINDING sites , *CYTOGENETICS , *GENETIC polymorphisms - Abstract
Rheumatoid arthritis is a common inflammatory disease with complex genetic components. We investigated the genetic contribution of the cytokine gene cluster in chromosome 5q31 to susceptibility to rheumatoid arthritis in the Japanese population by case-control linkage disequilibrium (LD) mapping using single nucleotide polymorphisms (SNPs). Here we report that there is significant association between rheumatoid arthritis and the organic cation transporter gene SLC22A4 (P = 0.000034). We show that expression of SLC22A4 is specific to hematological and immunological tissues and that SLC22A4 is also highly expressed in the inflammatory joints of mice with collagen-induced arthritis. A SNP affects the transcriptional efficiency of SLC22A4 in vitro, owing to an allelic difference in affinity to Runt-related transcription factor 1 (RUNX1), a transcriptional regulator in the hematopoietic system. A SNP in RUNX1 is also strongly associated with rheumatoid arthritis (P = 0.00035). Our data indicate that the regulation of SLC22A4 expression by RUNX1 is associated with susceptibility to rheumatoid arthritis, which may represent an example of an epistatic effect of two genes on this disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
24. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene
- Author
-
Yamada, Ryo, Suzuki, Akari, Chang, Xiotian, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *MEDICAL genetics , *JOINT diseases , *AUTOANTIBODIES , *IMMUNOGLOBULINS - Abstract
Recent studies using linkage disequilibrium and SNPs uncovered a rheumatoid arthritis (RA)-susceptible haplotype in the gene encoding peptidylarginine deiminase (PADI) type 4. This gene is one of four known PADI genes that encode enzymes to change arginine into citrulline in proteins. Post-translational modifications of proteins, including peptidyl citrullination, are related to autoimmunity, and peptidyl citrulline is a known target of one of the most RA-specific autoantibodies. Further research on PADI4, its citrullination of native peptides, subsequent breakdown of tolerance, and the role of these peptides in the development of RA, is expected to bring a better understanding of autoimmunity and arthritis, and advancements in the medical care of RA. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
25. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
- Author
-
Suzuki, Akari, Yamada, Ryo, Chang, Xiaotian, Tokuhiro, Shinya, Sawada, Tetsuji, Suzuki, Masakatsu, Nagasaki, Miyuki, Nakayama-Hamada, Makiko, Kawaida, Reimi, Ono, Mitsuru, Ohtsuki, Masahiko, Furukawa, Hidehiko, Yoshino, Shinichi, Yukioka, Masao, Tohma, Shigeto, Matsubara, Tsukasa, Wakitani, Shigeyuki, Teshima, Ryota, and Nishioka, Yuichi
- Subjects
- *
RHEUMATOID arthritis , *ARTHRITIS , *AUTOIMMUNE diseases - Abstract
Individuals with rheumatoid arthritis frequently have autoantibodies to citrullinated peptides, suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (encoded by PADI genes) in rheumatoid arthritis. Previous linkage studies have shown that a susceptibility locus for rheumatoid arthritis includes four PADI genes but did not establish which PADI gene confers susceptibility to rheumatoid arthritis. We used a case-control linkage disequilibrium study to show that PADI type 4 is a susceptibility locus for rheumatoid arthritis (P = 0.000008). PADI4 was expressed in hematological and rheumatoid arthritis synovial tissues. We also identified a haplotype of PADI4 associated with susceptibility to rheumatoid arthritis that affected stability of transcripts and was associated with levels of antibody to citrullinated peptide in sera from individuals with rheumatoid arthritis. Our results imply that the PADI4 haplotype associated with susceptibility to rheumatoid arthritis increases production of citrullinated peptides acting as autoantigens, resulting in heightened risk of developing the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
26. Association between a Single-Nucleotide Polymorphism in the Promoter of the Human Interleukin-3 Gene and Rheumatoid Arthritis in Japanese Patients, and Maximum-Likelihood Estimation of...
- Author
-
Yamada, Ryo, Tanaka, Toshihiro, Ohnishi, Yozo, Tsunoda, Tatsuhiko, Unoki, Motoko, Nakamura, Yusuke, Nagai, Tatsuo, Sawada, Tetsuji, Suzuki, Kenji, Yukioka, Masao, Maeda, Akira, Ochi, Takahiro, Tateishi, Hiroomi, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *INTERLEUKIN-3 , *PHYSIOLOGY - Abstract
Presents information on a study which examined the role of genetic variants of interleukin-3 (IL-3) in the pathophysiology of rheumatoid arthritis (RA) in Japan. Association between RA and a single-nucleotide polymorphism in the IL-3 promoter region; Methodology; Results and discussion.
- Published
- 2001
- Full Text
- View/download PDF
27. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs.
- Author
-
Mori, Mikako, Yamada, Ryo, Kobayashi, Kyoko, Kawaida, Reimi, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *AUTOIMMUNE diseases , *GENETIC research , *CELL death , *DIABETES , *AUTOIMMUNITY - Abstract
Several multiple, large-scale, genetic studies on autoimmune-disease-associated SNPs have been reported recently: peptidylarginine deiminase type 4 ( PADI4) in rheumatoid arthritis (RA); solute carrier family 22 members 4 and 5 ( SLC22A4 and 5) in RA and Crohn’s disease (CD); programmed cell death 1 ( PDCD1) in systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1D), and RA; and protein tyrosine phosphatase nonreceptor type 22 ( PTPN22) in T1D, RA, and SLE. Because these reports on association were not always evaluated in multiple ethnic groups and because ethnic difference in allele frequency of the variants has been also reported, we investigated allele frequencies of nine SNPs in four autoimmune-disease-associated loci in Caucasian, African-descent, and Japanese populations. Although SNPs in PADI4 had similar allele frequency among three groups [maximal difference 11%; ( P >0.05)], the other three loci revealed statistically significant allele frequency differences (maximal difference 39% ( P <0.00001), 13% ( P <0.00001), and 8% ( P <0.00001) in SLC22A4, PDCD1, and PTPN22, respectively). Of note, three SNPs in the three loci that had allele frequency more than 8% in the Caucasian population were either not polymorphic at all or extremely rare in the Japanese population. Our data suggest that ethnic variations of polymorphisms should be evaluated in detail, and differences should be incorporated into investigations of susceptibility variants for common diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
28. Ethnogenetic heterogeneity of rheumatoid arthritis--implications for pathogenesis.
- Author
-
Kochi, Yuta, Suzuki, Akari, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *ETIOLOGY of diseases , *HUMAN genome , *DISEASE susceptibility , *GENOTYPE-environment interaction - Abstract
Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are generally considered multifactorial--that is, they involve both genetic and environmental factors. Technical advances in human genetics over the past 5 years have enabled the survey of the entire human genome for disease susceptibility genes and have contributed to a greater understanding of the molecular mechanisms underlying autoimmunity. Among the genetic predisposition factors identified to date, some variants have been found to be restricted to specific ethnic groups, which might reflect migration history and the natural selection that shaped genetic variation in these populations. Other genetic factors could also have exerted different magnitudes of risk for the disease among the different populations, which might be explained by their interactions with other genetic and environmental factors. These pieces of evidence suggest that substantial heterogeneity exists in the genetics underlying autoimmunity among different ethnic populations, This Review discusses the genetic heterogeneity in autoimmunity, with a focus on rheumatoid arthritis, between Asian and European populations. In addition to the most-studied and well-characterized gene HLA-DRB1, we will also describe examples of the gene-environment interactions between PADI4 and smoking, and the gene-gene interactions between PTPN22 and FCRL3. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
29. Genetics of rheumatoid arthritis: Underlying evidence of ethnic differences
- Author
-
Kochi, Yuta, Suzuki, Akari, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
- *
POPULATION , *HUMAN ecology , *SOCIOLOGY , *ECONOMICS - Abstract
Abstract: A new age has begun in the genetics of rheumatoid arthritis (RA), as genome-wide association studies scanning the human genome have been put into practical use. Among the RA-susceptibility genes identified by genetic studies, HLA-DRB1 gene appears to represent the most major determinant of genetic predisposition to RA. However, inconsistent results of the contributions of non-HLA susceptibility genes have been described, with the exception of a few genes repeatedly associated with RA-susceptibility, such as PTPN22 gene in populations of European ancestry and PADI4 gene in populations of Asian ancestry, revealing the presence of genetic heterogeneity in RA. We review herein recent advances in the genetics of RA and discuss the underlying differences among populations of European and Asian ancestries, taking as examples our previous findings for RA-susceptibility genes in the Japanese population: PADI4; FCRL3; and CD244. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
30. Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population – The Nagahama study.
- Author
-
Terao, Chikashi, Asai, Keita, Hashimoto, Motomu, Yamazaki, Toru, Ohmura, Koichiro, Yamaguchi, Akihiko, Takahashi, Katsu, Takei, Noriko, Ishii, Takanori, Kawaguchi, Takahisa, Tabara, Yasuharu, Takahashi, Meiko, Nakayama, Takeo, Kosugi, Shinji, Sekine, Akihiro, Fujii, Takao, Yamada, Ryo, Mimori, Tsuneyo, Matsuda, Fumihiko, and Bessho, Kazuhisa
- Subjects
- *
RHEUMATOID arthritis treatment , *PERIODONTAL disease , *PEPTIDE drugs , *AUTOANTIBODIES , *RHEUMATOID factor , *IMMUNOGLOBULIN M - Abstract
Anti-citrullinated peptide antibody (ACPA) is a highly specific autoantibody to rheumatoid arthritis (RA). Recent studies have revealed that periodontal disease (PD) is closely associated with RA and production of ACPA in RA. Analyses of associations between PD and ACPA production in a healthy population may deepen our understandings. Here, we analyzed a total of 9554 adult healthy subjects. ACPA and IgM-rheumatoid factor (RF) was quantified and PD status was evaluated using the number of missing teeth (MT), the Community Periodontal Index (CPI) and Loss of Attachment (LA) for these subjects. PD status was analyzed for its association with the positivity and categorical levels of ACPA and RF conditioned for covariates which were shown to be associated with PD, ACPA or RF. As a result, all of MT, CPI and LA showed suggestive or significant associations with positivity ( p = 0.024, 0.0042 and 0.037, respectively) and levels of ACPA ( p ≤ 0.00031), but none of the PD parameters were associated with those of RF. These association patterns were also observed when we analyzed 6206 non-smokers of the participants. The significant associations between PD parameters and positivity and levels of ACPA in healthy population support the fundamental involvement of PD with ACPA production. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
31. Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis
- Author
-
Okazaki, Yuko, Suzuki, Akari, Sawada, Tetsuji, Ohtake-Yamanaka, Miyako, Inoue, Tetsufumi, Hasebe, Terumitsu, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
- *
IMMUNOGLOBULINS , *ANTIBODY diversity , *ARTHRITIS , *RHEUMATISM , *RHEUMATOID arthritis , *ANTIGENS , *SERUM , *BIOCHEMISTRY - Abstract
Abstract: Antibodies against citrullinated proteins are highly specific for rheumatoid arthritis. We previously reported that functional variants of the gene encoding peptidylarginine deiminase type 4 were closely associated with RA. The purpose of this study was to investigate the citrullinated autoantigens recognized by serum samples from patients with RA. The human chondrocyte cDNA expression library was citrullinated by PADI4 and was immunoscreened with anti-modified citrulline antibodies and sera from patients with rheumatoid arthritis. One immunoreactive cDNA clone containing a 2480-base pair insert was isolated and sequence analysis revealed that the cDNA included a part of the eukaryotic translation initiation factor 4G1. Immunoreactivity against a recombinant citrullinated eIF4G1 fragment was observed with high specificity in 50.0% of RA patients. The levels of antibodies against citrullinated eIF4G1 were correlated with those of anti-CCP antibodies. Citrullinated eIF4G1 was identified as a candidate citrullinated autoantigen in RA patients. Citrullination of eIF4G1 may thus be involved in the pathogenesis of RA. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
32. Comparison of enzymatic properties between hPADI2 and hPADI4
- Author
-
Nakayama-Hamada, Makiko, Suzuki, Akari, Kubota, Kazuishi, Takazawa, Tomoko, Ohsaka, Mizuko, Kawaida, Reimi, Ono, Mitsuru, Kasuya, Atsushi, Furukawa, Hidehiko, Yamada, Ryo, and Yamamoto, Kazuhiko
- Subjects
- *
RHEUMATOID arthritis , *AUTOANTIBODIES , *FIBRINOGEN , *PROTEINS - Abstract
Abstract: In the sera of rheumatoid arthritis (RA) patients, autoantibodies directed to citrullinated proteins are found with high specificity for RA. Peptidylarginine deiminases (PADIs) are enzymes responsible for protein citrullination. Among many isoforms of PADIs, only PADI4 has been identified as an RA-susceptibility gene. To understand the mechanisms of the initiation and progression of RA, we compared the properties of two PADIs, human PADI2 and human PADI4, which are present in the synovial tissues of RA patients. We confirmed their precise distribution in the RA synovium and compared the stability, Ca2+ dependency, optimal pH range, and substrate specificity. Small but significant differences were found in the above-mentioned properties between hPADI2 and hPADI4. Using LC/MS/MS analysis, we identified the sequences in human fibrinogen indicating that hPADI2 and hPADI4 citrullinate in different manners. Our results indicate that hPADI2 and hPADI4 have different roles under physiological and pathological conditions. Further studies are needed for the better understanding of the role of hPADIs in the initiation and progression of RA. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.